Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Ginkgo Bioworks Holdings Inc. Class A

Ginkgo Bioworks Holdings ( ($DNA) ) has shared an announcement. On April 3, 2026, Ginkgo Bioworks, Inc., a subsidiary of Ginkgo Bioworks Holdings, ...

Ginkgo Bioworks Divests Biosecurity Unit, Refocuses Core Operations

DeNA Co ( ($JP:2432) ) has shared an announcement. DeNA Co., Ltd. has disclosed the progress of its share repurchase program authorized by its boar...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DNA	$6.87	+0.73%	561.17K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DNA	$6.87	+0.7%	561.17K
3
4
5
6

DNA

DNA

No Data Available

Get Ginkgo Bioworks Holdings Inc. Class A Data in Excel

Get Ginkgo Bioworks Holdings Inc. Class A Data in Excel